Population pharmacokinetics of ramipril in patients with chronic heart failure: A real-world longitudinal study Cover

.blurhash-client-img { display: none !important; }

Population pharmacokinetics of ramipril in patients with chronic heart failure: A real-world longitudinal study

Acta Pharmaceutica

Volume 74 (2024): Issue 2 (June 2024)

By: Katja Čvan Trobec, Iztok Grabnar , Jurij Trontelj, Mitja Lainščak and Mojca Kerec Kos

Open Access

|May 2024

Authors

Katja Čvan Trobec

University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia

Iztok Grabnar

University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia

Jurij Trontelj

University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia

Mitja Lainščak

Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Division of Cardiology General Hospital Murska Sobota, Murska Sobota, Slovenia

Mojca Kerec Kos

kerecm@ffa.uni-lj.si

University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia

DOI: https://doi.org/10.2478/acph-2024-0018 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075

Journal RSS Feed

Language: English

Page range: 315 - 328

Accepted on: Apr 15, 2024

|

Published on: May 30, 2024

Published by: Croatian Pharmaceutical Society

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

pharmacokinetics,

chronic heart failure,

body composition

Related subjects:

Pharmacy, other

© 2024 Katja Čvan Trobec, Iztok Grabnar, Jurij Trontelj, Mitja Lainščak, Mojca Kerec Kos, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 74 (2024): Issue 2 (June 2024)Next article